Changes to the website
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4431

Previous 25           Next 25
Website Changes
04/19/2017 Cloud Over Pediatric Oncologist and Brain Cancer Vaccine
04/18/2017 FDA Okays Clinical Trial of Injectable Brain Cancer Drug - See more at:
04/17/2017 CNS Oncology Publishes Data Suggesting Survival Benefit of Optune™ in Combination with Second Line Chemotherapies after Glioblastoma Recurrence
04/17/2017 Survey on the use of animals in brain cancer research
04/14/2017 Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
04/14/2017 Medicenna Treats First Patient in Phase 2b Recurrent Glioblastoma Trial
04/12/2017 Feinstein Institute examines use of antiparasitic drug as new treatment for brain tumors
04/09/2017 DFFN: Phase 3 Trial of TSC in GBM to Initiate in 2017
04/07/2017 A Proposed New FDA Drug Approval Pathway: “Conditional Approval”
04/06/2017 Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity
04/06/2017 Tocagen wins "Most Successful Early Phase Trial" and "Excellence in Rare Disease Drug Development" awards!
04/06/2017 Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
04/05/2017 Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
04/05/2017 DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting
04/03/2017 "Sci-fi" cancer therapy fights brain tumors, study finds
03/29/2017 MGH/Dana Farber Initiate Expansion of ONC201 Glioblastoma Trial
03/21/2017 VBI Vaccines Building On Duke University Research for New Cancer Therapy
03/20/2017 Is it time for "Conditional Approvals"?
03/17/2017 Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.
03/17/2017 Antibody treats pediatric brain tumors safely and effectively in mice
03/17/2017 Medicenna BioPharma Announces Strategic Collaboration with MD Anderson Cancer Center to Advance Next Generation Empowered Cytokines™
03/10/2017 Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.
03/10/2017 Ependymoma Awareness Day.
03/10/2017 Clinical Trial Announcement Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Glioblastoma at First Recurrence or Progression

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites